4-Amino-N-methylbenzeneethanesulfonamide → 2-(4-{4-[(2-Benzylamino-1-ethyl-1H-benzoimidazol-5-yl)-methyl-amino]-pyrimidin-2-ylamino}-phenyl)-ethanesulfonic acid methylamide hydrochloride
Reaction equation
[CH2:1]([NH:8][C:9]1[N:13]([CH2:14][CH3:15])[C:12]2[CH:16]=[CH:17][C:18]([N:20]([C:22]3[CH:27]=[CH:26][N:25]=[C:24]([Cl:28])[N:23]=3)[CH3:21])=[CH:19][C:11]=2[N:10]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[CH3:29][NH:30][S:31]([CH2:34][CH2:35][C:36]1[CH:41]=[CH:40][C:39]([NH2:42])=[CH:38][CH:37]=1)(=[O:33])=[O:32]>>[ClH:28].[CH3:29][NH:30][S:31]([CH2:34][CH2:35][C:36]1[CH:37]=[CH:38][C:39]([NH:42][C:24]2[N:23]=[C:22]([N:20]([C:18]3[CH:17]=[CH:16][C:12]4[N:13]([CH2:14][CH3:15])[C:9]([NH:8][CH2:1][C:2]5[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=5)=[N:10][C:11]=4[CH:19]=3)[CH3:21])[CH:27]=[CH:26][N:25]=2)=[CH:40][CH:41]=1)(=[O:32])=[O:33]Participants
3
Procedure
The title compound was prepared following the procedure of example two with N2-Benzyl-N5-(2-chloro-pyrimidin-4-yl)-1-ethyl-N5-methyl-1H-benzoimidazole-2,5-diamine (98 mg, 0.25 mmol) and 2-(4-amino-phenyl)-ethanesulfonic acid methylamide (54 mg, 0.25 mmol) as a white solid (74 mg, 49%). 1H NMR (300 MHz, d6-DMSO+NaHCO3) δ 9.04 (s, 1H), 7.75 (d, J=6.0 Hz, 1H), 7.69 (d, J=8.4 Hz, 2H), 7.23-7.42 (m, 7H), 7.07-7.12 (m, 3H), 6.94 (q, J=5.1 Hz, 1H), 6.83 (dd, J=8.4 and 2.1 Hz, 1H), 5.63 (d, J=5.7 Hz, 1H), 4.61 (d, J=5.7 Hz, 2H), 4.11 (q, J=6.9 Hz, 2H), 3.41 (s, 3H), 3.32 (s, 3H), 3.20-3.25 (M, 2H), 2.83-2.88 (M, 2H), 2.59 (d, J=4.8 Hz, 3H), 1.26 (t, J=6.9 Hz, 3H). MS (ESI) m/z=571 [M+H]+.
Sources & evidence
- ORD record
- ord-d5043ee4fbcd4d53971e56fd49ef83d0
- Source dataset
- uspto-grants-2008_03
- Patent number
- US07338959B2
Reaction notes
Loading…